MREO
Mereo BioPharma
MREO
MREO
60 hedge funds and large institutions have $99.6M invested in Mereo BioPharma in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 22 increasing their positions, 12 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
32% less capital invested
Capital invested by funds: $146M → $99.6M (-$46.1M)
80% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 15
Holders
60
Holding in Top 10
–
Calls
$81K
Puts
$1K
Top Buyers
| 1 | +$19.3M | |
| 2 | +$991K | |
| 3 | +$689K | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$548K |
| 5 |
BlackRock
New York
|
+$312K |
Top Sellers
| 1 | -$3.49M | |
| 2 | -$1.6M | |
| 3 | -$534K | |
| 4 |
CAM
Connacht Asset Management
New York
|
-$341K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$157K |